| Name | 5-ethynyluridine |
|---|---|
| Synonyms |
Uridine, 5-ethynyl
5-Ethynyl-Ur 5-Ethynyl Uridine (5-EU) (CCT-1261) 5-Ethynyluridine ,E1255 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-ethynylpyrimidine-2,4(1H,3H)-dione 5-Ethynyluridine (5-EU) 5-Ethynyl Uridine (EU) 5-EU 5-Ethynyluridine (5-EU), Uridine analog EU(5-Ethynyl-uridine) 5-ETHYNYL URIDINE 5-Ethynyluridine, 10 mM in DMSO 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-ethynylpy 5-EU,neurons,purkinje cells,Inhibitor,nascent RNA,5 Ethynyluridine,5-Ethynyluridine,RNA transcripts,5Ethynyluridine,inhibit 5-ETHYNYL URIDINE; 1-((2R,3R,4S,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-5-ETHYNYLPY |
| Description | 5-Ethynyluridine (5-EU) is a potent cell-permeable nucleoside can be used to label newly synthesized RNA. 5-Ethynyluridine can be used for isolation and sequencing of nascent RNA from neuronal populations in vivo. 5-Ethynyluridine can be used to identify changes in transcription in vivo in nervous system disease models[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | 5-Ethynyluridine (75 mM in PBS for 1 µl; intracerebellar injection ) shows a labeling of central nervous system cells in mouse[1]. 5-Ethynyluridine (330-750 µMol/g; i.p.) results in in labelling of nascent RNA in cells of multiple organs and tissues, but not in the central nervous system in mouse[1]. |
| References |
| Molecular Formula | C11H12N2O6 |
|---|---|
| Molecular Weight | 268.22300 |
| Exact Mass | 268.07000 |
| PSA | 124.78000 |
|
~%
69075-42-9 |
| Literature: Chemical Communications, , vol. 49, # 30 p. 3128 - 3130 |
|
~%
69075-42-9 |
| Literature: Chemical Communications, , vol. 49, # 30 p. 3128 - 3130 |
|
~%
69075-42-9 |
| Literature: Chemical Communications, , vol. 49, # 30 p. 3128 - 3130 |
|
~%
69075-42-9 |
| Literature: Chemical Communications, , vol. 49, # 30 p. 3128 - 3130 |
|
~%
69075-42-9 |
| Literature: Chemical Communications, , vol. 49, # 30 p. 3128 - 3130 |
| Precursor 5 | |
|---|---|
| DownStream 0 | |